THE TECHNOLOGY BLIND SPOT
“You can take change by the hand, or it will grab you by the throat.” That Churchill aphorism surfaced recently in a Financial Times profile of the Dudley DeBosier acquisition. In January 2026, Uplift Investors, a private equity fund, acquired a controlling interest in Dudley DeBosier, a 135-attorney personal injury firm across Louisiana and Texas, through what the industry calls a Management Services Organization. The MSO structure allows PE to control the firm’s business operations while technically leaving legal practice under attorney supervision. Uplift announced the formation of Orion Legal MSO with plans to acquire additional firms in “underserved markets.”
To understand what that means, attorneys need to understand how private equity actually works, what happens when PE targets a professional services industry, and why the healthcare precedent should inform every managing partner’s strategic thinking. This analysis examines the evidence on both sides, including legitimate arguments for PE investment in legal services, and offers a framework for evaluating what lies ahead.
The Direct Answer
Private equity is already inside the legal industry. The only question is scale. With $2.62 trillion in dry powder, a profession generating $396 billion in annual revenue, and regulatory barriers weakening across multiple jurisdictions, PE firms have identified legal services as the next frontier for consolidation. The pattern follows a well-documented playbook: target fragmented, high-margin industries with recurring revenue, acquire through leveraged structures, extract value through financial engineering, and exit within three to seven years. Whether this process creates or destroys value depends entirely on execution, incentive alignment, and the regulatory guardrails that remain standing.
Attorneys who understand the mechanics, study the precedents from healthcare and technology, and invest in operational independence now will navigate this transition from a position of strength. Those who dismiss it will face the same choice that confronted independent physicians a decade ago: accept terms dictated by financial sponsors, or compete against well-capitalized platforms with bare hands.
How Private Equity Works: The Mechanics of the Machine
Private equity, at its core, is a form of alternative investment in which funds pool capital from institutional investors, known as limited partners (LPs), including pension funds, endowments, sovereign wealth funds, and wealthy individuals. The general partner (GP) manages the fund, identifies acquisition targets, executes transactions, and oversees portfolio company operations. The GP typically contributes 1-5% of the fund’s total capital and receives management fees (usually 2% of committed capital annually) plus carried interest (typically 20% of profits above a hurdle rate).
The basic mechanics follow a well-established sequence. During fundraising, PE firms raise committed capital from LPs, who pledge to provide funds when called. This committed-but-undeployed capital, known as dry powder, stood at $2.62 trillion globally as of mid-2025, according to S&P Global Market Intelligence. Buyout-specific dry powder exceeded $1.1 trillion. These figures represent the largest capital reserves in PE history.
In target identification, PE firms look for specific characteristics: recurring or predictable revenue streams, high profit margins, fragmented markets ripe for consolidation, and operational inefficiencies that financial engineering can address. Professional services industries, including accounting, dental practices, veterinary clinics, and now legal services, check every box.
The defining financial characteristic of most PE acquisitions is leverage. PE firms typically finance acquisitions using 60-70% debt and 30-40% equity. The acquired company, not the PE fund, carries the debt on its balance sheet. This structure amplifies returns on equity when the investment succeeds and shifts downside risk to the portfolio company and its creditors when it fails. A Harvard Business School working paper by Lietz and Chvanov (2024) found that average and median PE funds have not outperformed their public market equivalents since the Global Financial Crisis, raising fundamental questions about whether the leverage-driven model still delivers on its core promise.
Once acquired, PE firms implement operational changes designed to increase the company’s resale value within the investment horizon: cost reduction, revenue optimization, add-on acquisitions to build scale, and management restructuring. The GP’s incentive structure rewards maximizing exit value, which does not always align with long-term organizational health. As Gompers, Kaplan, and colleagues noted in their November 2025 Harvard Business Review article, PE-backed companies consistently deliver faster gains than public or family-owned peers. The critical question is whether “faster” equates to “sustainable.”
PE firms realize returns through exit events: selling to another PE fund (secondary buyout), selling to a strategic acquirer, or taking the company public through an IPO. The typical holding period has stretched to approximately five years, according to Wachtell Lipton’s 2025 review, up from 4.2 years in 2021-2022, reflecting the difficulty of finding profitable exits in current market conditions.
The Scale of Capital: What Happens When PE Targets an Industry
The sheer volume of deployable capital in private equity is difficult to overstate. When the combined PE market identifies a new sector for consolidation, the capital available dwarfs the target industry’s total enterprise value.
The numbers tell the story. Global PE dry powder across all strategies stands at $2.62 trillion. Buyout-specific dry powder exceeds $1.1 trillion. The entire U.S. legal services market generated approximately $396 billion in revenue in 2024, projected to grow to $462 billion by 2030 according to Grand View Research. That means buyout-focused PE alone commands enough undeployed capital to acquire the equivalent of nearly three times the U.S. legal industry’s annual revenue. Even a small allocation toward legal services represents transformative capital.
Consider the arithmetic. The U.S. has approximately 436,000 law firms. The overwhelming majority are solo practices or firms with fewer than ten attorneys. Solo practitioners account for roughly 50% of all firms but capture a fraction of total revenue. Mid-market firms, those generating $2 million to $50 million annually, represent the sweet spot for PE roll-up strategies: large enough to justify acquisition costs, small enough to lack bargaining power, and numerous enough to enable rapid platform building. As Blackstone CEO Stephen Schwarzman stated on a recent earnings call: “Some best times to deploy capital are in a risk-off environment. When others are not committing capital, it’s a terrific time for us to be doing that.”
The Value Equation: How PE Creates and Destroys
A fair assessment of private equity requires acknowledging both sides of the ledger. PE has generated legitimate value in numerous portfolio companies through operational discipline, technology investment, and management professionalization. The McKinsey Global Private Markets Report (2025) documented that add-on acquisitions accounted for 40% of total PE buyout deal value in 2024, and consolidation-driven strategies can produce genuine efficiencies through centralized procurement, harmonized technology systems, and unified go-to-market approaches.
The HBS research, however, tells a more complicated story. Lietz and Song’s September 2024 working paper, “Does Private Equity Have Any Business Being in the Health Care Business?,” examined the specific mechanisms through which PE ownership affects service quality in professional settings. The CFA Institute’s August 2024 analysis asked bluntly whether PE constitutes, “in essence, plunder.” The U.S. Senate Joint Economic Committee compiled extensive evidence of value destruction in its July 2024 report on predatory PE practices.
Research compiled by these institutions has identified several recurring extraction patterns that apply across industries.
Dividend Recapitalization
The acquired company borrows money not to invest in growth, but to pay dividends back to the PE fund. This weakens the company’s balance sheet while allowing the PE firm to recover its equity investment, sometimes within the first two years. Cano Health, a PE-backed primary care provider, paid over $100 million in dividend recapitalizations before filing Chapter 11 bankruptcy in February 2024. Creditors and employees absorbed the losses. The PE sponsors had already extracted their returns.
Sale-Leaseback
PE firms sell the acquired company’s real estate to a separate entity, often PE-affiliated, and force the company to lease back the same space at market or above-market rates. This generates immediate cash for the PE fund while converting a fixed asset into a recurring liability for the portfolio company. Steward Health Care’s collapse illustrated this pattern: the PE owner sold hospital properties, then the health system could no longer sustain the lease payments.
Roll-Up Consolidation and Price Manipulation
PE firms acquire multiple competitors in a market to create dominant positions, then raise prices. The Federal Trade Commission filed suit against U.S. Anesthesia Partners in September 2023, alleging that the PE-backed company systematically acquired competing anesthesiology practices in Texas to create a near-monopoly, then raised prices on patients who had no alternative providers.
Cost Reduction Through Quality Degradation
PE firms under return pressure cut costs in ways that directly degrade service quality. In healthcare, peer-reviewed research published in JAMA found that hospital-acquired conditions increased significantly following PE acquisition. A National Bureau of Economic Research study by Gupta et al. documented that PE-acquired nursing homes experienced a 10% increase in mortality among Medicare patients, translating to over 20,000 additional deaths during the study period.
The Technology Precedent: Elliott Management and Juniper Networks
Healthcare is not the only industry where financial engineering has undermined competitive capacity. The technology sector offers a case study that speaks directly to the risks facing professional services firms.
In January 2014, Elliott Management, one of the world’s most aggressive activist investment firms, disclosed a 6.2% stake in Juniper Networks, the second-largest enterprise networking company behind Cisco Systems. Elliott’s investment, valued at approximately $1.3 billion, came with a specific demand: return $3.1 billion to shareholders through a combination of an immediate $2 billion share repurchase program, an additional $1 billion in buybacks over the following year, and a new quarterly dividend of $0.125 per share.
The campaign followed activist investing’s standard playbook. Elliott argued that Juniper held excessive cash reserves and that management had failed to maximize shareholder value. By March 2014, Juniper settled with Elliott, agreeing to a $2 billion accelerated share repurchase, $160 million in operating expense cuts, a 6% workforce reduction (approximately 600 employees), and two Elliott-nominated directors on the board.
The short-term financial results looked impressive. Share buybacks reduced outstanding shares, boosting earnings per share. Operating expense cuts improved margins temporarily. Elliott and other large shareholders captured immediate returns.
The long-term competitive consequences proved devastating. Juniper’s revenue, which stood at $4.63 billion in 2014, stagnated through 2017 and then declined. The company had starved R&D investment precisely when the networking industry required massive strategic pivots toward software-defined networking (SD-WAN), cloud infrastructure, and subscription-based service models. As a Futuriom industry analysis noted, Juniper’s “business and marketing message is still largely built around moving hardware,” and the company “remains behind the curve in promising areas such as SD-WAN.” By February 2018, Juniper’s cloud vertical revenue had declined 37% in a single quarter.
Cisco, which maintained its R&D spending and pivoted aggressively to software subscription models and intent-based networking, consolidated its dominant position, holding over 70% market share in enterprise networking. Juniper, once a genuine competitive alternative in core routing and switching, became a marginal player. Buyer choice narrowed. Price floors solidified. Enterprise customers paid the cost of reduced competition.
The endpoint tells the full story. In January 2024, Hewlett Packard Enterprise announced its acquisition of Juniper Networks for $14 billion. A company that once challenged Cisco’s networking dominance, that employed thousands of engineers building alternative approaches to enterprise infrastructure, ended its independent existence a decade after activist investors redirected its capital from R&D to shareholder distributions. The $3.1 billion returned to shareholders bought a decade of strategic drift that destroyed far more in enterprise value than it returned in buybacks.
For law firms evaluating PE partnerships, the Juniper case illuminates a critical risk: financial sponsors optimize for returns within their investment horizon, not for the competitive positioning that sustains a professional services firm over decades. The R&D equivalent in legal services is talent development, technology adoption, and client relationship investment. Strip those to fund distributions, and the firm may look more profitable for three to five years while losing the capabilities that justified its existence.
The Healthcare Cautionary Tale
Healthcare provides the most instructive analogue for the legal industry. The parallels are precise. Both industries feature professional licensing requirements, ethical obligations to vulnerable clients/patients, fragmented markets dominated by small practices, high barriers to entry, and information asymmetries that create trust-dependent relationships. Healthcare also had its own version of Rule 5.4: the corporate practice of medicine doctrine, which prohibited nonphysician ownership of medical practices in most states.
PE navigated around those restrictions using the same MSO model now targeting legal services. The MSO acquired the practice’s business operations, facilities, equipment, and nonmedical staff while a nominally independent physician retained “control” over clinical decisions. In practice, the MSO controlled scheduling, staffing levels, billing, vendor relationships, and capital allocation. The physician’s clinical independence became increasingly theoretical.
The results of PE’s healthcare campaign are sobering. PE firms now own approximately 30% of all for-profit U.S. hospitals, according to the Center for American Progress’s October 2025 analysis. PE-backed healthcare bankruptcies have surged, with Steward Health Care, Envision Healthcare, and Cano Health all filing for Chapter 11 after PE ownership loaded them with unsustainable debt. A National Bureau of Economic Research study found PE-acquired nursing homes experienced significantly higher mortality rates, translating to over 20,000 additional deaths during the study period. JAMA research documented increased hospital-acquired conditions following PE takeover.
As one Missouri medical journal editorial observed, the corporate practice of law is prohibited in every state, meaning nonlawyers cannot own or control a law firm. Yet the MSO model that circumvented medicine’s equivalent protection is already operational in legal services.
The Lobbying Playbook: How PE Changes the Rules
The healthcare precedent reveals something beyond financial engineering: a systematic campaign to weaken the regulatory barriers that protected professional independence. PE did not simply work around corporate practice restrictions. It actively lobbied to eliminate them.
The American Investment Council, private equity’s primary trade group, publicly opposed California’s AB 3129 in 2024, the bill that would have required state approval for PE acquisitions of healthcare facilities. The AIC stated it “worked with our coalition partners to improve this legislation but remain concerned that the current bill sends the wrong message to the business community about investing in California.” Governor Newsom vetoed the bill.
The lobbying pattern extends across states and industries. PE-backed entities challenged corporate practice of medicine restrictions in state after state, exploiting jurisdictional differences through MSO structures where direct ownership remained prohibited. They opposed transaction review requirements that would have given regulators visibility into acquisition terms. They resisted transparency mandates that would have disclosed ownership structures, debt levels, and management fee arrangements. The DLA Piper analysis of state legislative trends documented PE industry engagement across at least fifteen states, including Oregon, Nevada, Colorado, Minnesota, California, New York, and Illinois.
The regulatory tide turned in 2025, though the industry’s lobbying apparatus remains formidable. California enacted SB 351 and AB 1415, effective January 1, 2026, explicitly prohibiting PE firms from exercising control over clinical decision-making in physician and dental practices and requiring transaction reporting to the state’s Office of Health Care Affordability. Oregon passed SB 951, prohibiting MSOs controlled by PE funds from exercising de facto control over medical practices. Massachusetts, Indiana, New Mexico, and Maine enacted their own restrictions. Pennsylvania and Illinois advanced attorney general review powers over healthcare transactions.
This pattern should alarm attorneys for a specific reason. The legal profession’s primary protective barrier, ABA Model Rule 5.4, faces the same erosion strategy. Arizona eliminated Rule 5.4 restrictions in 2020. Utah launched a regulatory sandbox. The ABA’s Standing Committee on Ethics, Professional Responsibility, and Professional Regulation has recommended studying reforms. In January 2025, Texas Ethics Committee Opinion 704 allowed limited passive nonlawyer investment in law firms under specific conditions. If PE lobbied to weaken healthcare’s corporate practice protections, and those protections fell state by state over a decade, why would the legal profession’s equivalent barriers prove more durable?
What This Means for the Legal Industry
The legal industry sits at an inflection point. Several converging forces are making law firms increasingly attractive to PE.
The Regulatory Wall Is Weakening
ABA Model Rule 5.4, which prohibits nonlawyer ownership of law firms and fee-sharing with nonlawyers, has historically served as the primary barrier to PE entry. That barrier is eroding. Arizona’s elimination of Rule 5.4 restrictions has produced tangible results: in three years, 136 licensed Alternative Business Structure entities have emerged offering legal services under new ownership models, according to Stanford Law School’s Center on the Legal Profession. California’s AB 931, currently under Senate review, would prohibit nonlawyer ownership of law firms, representing a countervailing force. The regulatory picture is not uniformly permissive, but the trend line favors relaxation.
And critically, the MSO model bypasses Rule 5.4 entirely. PE acquires a law firm’s nonlegal operations, including facilities, technology, marketing, billing, HR, and administrative staff, while leaving the legal practice under nominal attorney control. This is the identical structure PE used in healthcare. As a Sidley Austin analysis from late 2025 noted, PE’s interest in investing in U.S. law firms has intensified dramatically, and the MSO model “allows private equity to invest in the business operations of law firms without running afoul of Rule 5.4.”
The PE Playbook Is Already Running
The pattern is visible. In England, Lawfront, backed by PE group Blixt, has assembled a legal services business that surpasses £130 million in combined revenue by acquiring six regional law firms. In the United States, Uplift Investors’ acquisition of Dudley DeBosier through the Orion Legal MSO demonstrates the model working in real time. The question is not whether PE will enter U.S. legal services at scale, but when.
The Consolidation Math
Of the 436,000 U.S. law firms, the vast majority are small practices with thin margins, limited technology adoption, and no succession plan. The 2024 Legal Trends Report found that solo and small firms collect only about 87 cents of every dollar they bill, with the average attorney recording just 3.0 billable hours per day. As documented in “The Leverage Trap,” the traditional BigLaw model has deteriorated with associate-to-partner ratios declining from 2:1 in 2000 to 1.3:1 by 2025, while billing rates escalated 6.5% in 2024 alone. These are precisely the conditions that PE has exploited in every sector it has consolidated: fragmented markets of independent operators, operational inefficiency that financial engineering can address in the short term, and a reluctant industry facing structural change it has deferred for decades.
The Case for PE Investment: Why Proponents May Be Right
The strongest argument for PE in legal services is not financial efficiency. It is access to justice.
The United States, despite hosting one of the largest pools of lawyers in the world, ranks 109th out of 128 countries in access to and affordability of civil justice, according to the World Justice Project’s 2024 Rule of Law Index. Approximately 80% of civil legal needs go unmet among low-income Americans. Solo and small firms, which serve the majority of individual clients, often lack the capital to invest in technology, marketing, or operational improvements that could expand access. If PE capital funds technology adoption that reduces costs and expands reach, the access-to-justice argument has genuine force.
The Arizona ABS experiment lends some support to this argument. In three years, 136 licensed entities have emerged offering legal services under new ownership models. Several have focused specifically on underserved populations and practice areas where traditional firms have not invested.
Proponents also point out that the legal profession’s self-regulatory apparatus has not solved its own operational problems. The profession has discussed modernization for decades while resisting every structural reform. If the choice is between PE-driven modernization and continued stagnation, the status quo carries its own costs, particularly for the clients who cannot access affordable legal services under the current model.
This argument has real force. But it depends entirely on execution and incentive alignment. The same access-to-justice rationale supported PE’s entry into healthcare. The results, in many documented cases, included higher prices, lower quality, and catastrophic bankruptcies that left communities without hospitals. The question is not whether PE can improve legal services in theory, but whether the financial incentive structure, optimized for returns within a five-year hold period, produces sustainable improvement or short-term extraction followed by decline.
Practice-Specific Implications
Personal Injury: PI firms are the first targets, as the Dudley DeBosier/Uplift deal demonstrates. High case volumes, predictable fee structures, and advertising-driven intake models fit the PE consolidation playbook precisely. Expect roll-ups across plaintiff-side practices, centralized intake and marketing, and pressure to maximize case volume over case quality.
Family Law: Contested divorces and custody disputes generate recurring, predictable revenue. PE consolidation could centralize intake across regions while deploying AI-assisted document production, following the template documented in “Why Hackers Target Law Firms” where centralized client data creates both efficiency and vulnerability.
Estate Planning: High-volume estate planning, including simple wills, trusts, and power of attorney documents, fits the standardization model that PE favors. The risk: the same pressure to maximize volume that degraded patient care in PE-owned healthcare practices could reduce the individualized attention that effective estate planning requires.
Criminal Defense: Defense strategy, witness handling, and plea negotiations involve irreducible human judgment that resists standardization. Criminal defense may prove the most resistant practice area to PE consolidation, though public defender operations and high-volume misdemeanor practices could face platform competition.
Corporate and M&A: Ironically, the practice area most familiar with PE mechanics faces its own vulnerability. Mid-market transactional firms that cannot match either elite relationship capital or platform cost efficiency occupy the space most susceptible to compression, a dynamic explored in detail in “The Leverage Trap.”
The Risk to Professional Independence
The most consequential risk is not financial. It is structural. The ABA’s restrictions on nonlawyer ownership exist to ensure that attorneys’ professional judgment remains free from external commercial pressure. When a PE firm controls a law firm’s business operations through an MSO, the theoretical separation between “business decisions” and “legal decisions” becomes difficult to maintain. Staffing levels affect case quality. Technology choices affect client communication security. Marketing strategies affect case selection. Capital allocation determines whether the firm invests in talent development or distributes cash to investors.
The Juniper Networks experience illustrates this dynamic outside the legal context. When financial sponsors controlled capital allocation decisions, they optimized for short-term returns, and the company lost the R&D investment that sustained its competitive position. In a law firm context, the equivalent would be reducing associate training, deferring technology security upgrades, increasing caseloads per attorney, or cutting support staff. Each “business decision” directly affects the quality of legal representation. As explored in “The Email Privacy Illusion” and “Your Phone Calls Are Being Recorded,” technology decisions carry direct ethical implications under Model Rules 1.1 and 1.6. An MSO making those decisions for cost-optimization purposes may not weigh professional responsibility obligations the same way a managing partner would.
Proponents argue that PE capital could fund technology adoption, expand access, and modernize an industry that has resisted change for generations. The healthcare evidence suggests that initial investment phases often do bring genuine improvements, including better facilities, updated equipment, and professional management. The extraction phase follows. The question is whether the legal profession can design guardrails that capture PE’s operational benefits while preventing the value extraction that devastated healthcare.
What Attorneys Should Do Now
Understand the MSO model and its implications. PE does not need to own your law firm to control its economics. An MSO that manages billing, staffing, facilities, and technology makes the critical business decisions that shape practice quality. Study how MSOs operate in healthcare before evaluating any partnership.
Invest in operational excellence now. PE targets firms that are operationally inefficient. Law firms that have already modernized their technology, optimized their billing practices, and built recurring revenue streams are less attractive acquisition targets because the PE “improvement” thesis has less room to operate. As “Your Password Is the Weakest Link” documented, basic technology competence is both an ethical obligation and a competitive necessity.
Evaluate your capital structure. Firms carrying significant debt or lacking capital reserves are the most attractive acquisition targets because they have the fewest alternatives. Build financial resilience before the consolidation wave makes independence more expensive to maintain.
Monitor regulatory developments. The status of Rule 5.4 in your jurisdiction, the expansion of ABS licensing, the evolution of MSO oversight, and the PE lobbying campaign against professional independence restrictions all require ongoing attention. Texas Opinion 704 (April 2025) signals that even conservative jurisdictions are reconsidering nonlawyer investment boundaries.
Study the healthcare precedent. Before entertaining any PE partnership, examine the documented outcomes in healthcare. Understand the trajectory from initial investment to dividend recapitalization to quality degradation to bankruptcy. The pattern is not inevitable, but ignoring it is negligent.
The Question of Leadership
The legal profession’s response to private equity will reveal something fundamental about its leadership.
Every industry PE has entered faced a version of this moment. Healthcare’s physician leaders, confronting the same capital pressures and regulatory circumvention, largely failed to organize a collective response. Individual practices sold to MSOs one by one, each transaction seemingly rational in isolation, collectively devastating in aggregate. By the time state legislatures mobilized to enact restrictions in 2025, PE already controlled 30% of for-profit hospitals and had reshaped emergency medicine, anesthesiology, and primary care delivery across the country. The restrictions came a decade late for the physicians who had already lost their practices and the patients who had already lost their community hospitals.
Juniper Networks’ board faced an analogous leadership test. When Elliott Management demanded $3.1 billion in shareholder distributions, the board could have made the case that competitive survival in enterprise networking required sustained R&D investment, that returning capital at the cost of strategic capability would destroy more value than it created. The board capitulated. A decade later, the company no longer exists as an independent entity.
The legal profession has advantages that healthcare and technology companies did not. Bar associations provide collective governance structures. Professional responsibility rules create enforceable standards. The judiciary has an independent interest in preserving the quality of legal representation. And a growing body of evidence from other industries illuminates both the benefits and the catastrophic risks of PE consolidation.
The profession also faces a generational divide that complicates the response. Managing partners approaching retirement see PE acquisition as a liquidity event and succession solution. Associates and junior partners, who would bear the long-term consequences of PE ownership, often lack the institutional authority to influence the decision. The 2024 Legal Trends Report found declining satisfaction among younger attorneys, many of whom are already considering alternatives to traditional firm practice. If PE acquires the firms they leave, the profession’s talent pipeline narrows further.
What kind of leadership does this moment require? Not reflexive opposition to all outside investment. Not uncritical embrace of PE capital as a modernization savior. Rather, the profession needs leaders who can distinguish between capital that builds sustainable capacity and capital that extracts value within a holding period. Leaders who study the MSO structures proposed by PE and insist on transparency, accountability, and enforceable protections for professional independence. Leaders who invest in the operational improvements that make PE’s “fix the inefficiency” thesis irrelevant by fixing it themselves. Leaders who recognize that the access-to-justice crisis is real and demands innovation, but who refuse to accept that the only available innovation comes attached to a leveraged buyout.
Churchill’s observation about change applies with particular force to institutions that believe their traditions make them immune. The legal profession has survived for centuries by adapting, reluctantly and imperfectly, to forces larger than itself. The printing press, the railroad, the telegraph, the internet, and now artificial intelligence and institutional capital, each forced a reckoning with practices the profession considered permanent.
Private equity is neither the profession’s salvation nor its executioner. It is a test of whether the legal profession’s leaders can do what healthcare’s leaders largely could not: shape the terms of transformation rather than be shaped by them.
The gathering storm will not wait for the profession to reach consensus. It requires action, informed by evidence, guided by professional obligation, and executed with the urgency that $2.62 trillion in deployable capital demands. The attorneys who lead that response will define the profession for a generation. The question is whether they will step forward before the choice is no longer theirs to make.
This blog provides general information for educational purposes only and does not constitute legal advice. Consult qualified counsel for advice on specific situations.
About the Author
JD Morris is Co-Founder and COO of LexAxiom. With over 20 years of enterprise technology experience and credentials including an MLS from Texas A&M, MEng from George Washington University, and dual MBAs from Columbia Business School and Berkeley Haas, JD focuses on the intersection of legal technology, cybersecurity, and professional responsibility.
Connect: LinkedIn | X | Bluesky
References
Bain & Company, Global Private Equity Report 2025
S&P Global Market Intelligence, PE Dry Powder Analysis (July 2025)
McKinsey & Company, Global Private Markets Report 2025
Wachtell, Lipton, Rosen & Katz, Private Equity: 2024 Review and 2025 Outlook (January 2025)
Lietz, N.G. & Chvanov, P., “Does the Case for Private Equity Still Hold?” Harvard Business School Working Paper No. 24-066 (January 2024)
Lietz, N.G. & Song, Z., “Does Private Equity Have Any Business Being in the Health Care Business?” Harvard Business School Working Paper No. 25-012 (September 2024)
Gompers, P., Kaplan, S.N. et al., “What Every Company Can Learn from Private Equity,” Harvard Business Review, November-December 2025
Sidley Austin LLP, Private Equity Investment in U.S. Law Firms (November 2025)
Reed Smith LLP, Private Equity and the Business of Law: Recent Market Trends (February 2026)
U.S. Senate Joint Economic Committee, Predatory Private Equity Practices (July 2024)
CFA Institute, “Private Equity: In Essence, Plunder?” (August 2024)
PMC / National Institutes of Health, The Harm from Private Equity’s Takeover of Medical Practices (2024)
Center for American Progress, 5 Consequences of PE Expansion in Health Care (October 2025)
Gupta, A. et al., “Does Private Equity Investment in Healthcare Benefit Patients? Evidence from Nursing Homes,” NBER Working Paper (2021)
Song, Z. et al., “Hospital-Acquired Conditions Following Private Equity Acquisition of Hospitals,” JAMA (2023)
Elliott Management / Juniper Networks Proxy Contest and Settlement (March 2014); Bloomberg, CNBC reporting
Futuriom, “What Juniper’s Quarter Says About Routers” (February 2018)
Juniper Networks Revenue Data, 2013-2023 (Statista, February 2024)
HPE Acquisition of Juniper Networks for $14 Billion (Announced January 2024, Closed 2025)
Private Equity Stakeholder Project, “New California Laws Regulate Private Equity in Healthcare” (October 2025)
Cooley LLP, “California’s New Laws: What Private Equity Needs to Know About Healthcare Investment Restrictions” (December 2025)
DLA Piper, “A Growing State of Oversight: How States Are Reshaping Healthcare Transactions and PE Investment” (June 2025)
American Investment Council, Statement on California AB 3129 (2024)
California SB 351 and AB 1415, effective January 1, 2026
Oregon SB 951, signed June 9, 2025
Federal Trade Commission v. U.S. Anesthesia Partners, Inc. (September 2023)
Berkeley Law, The Last Frontier: Why Private Equity Wants a Piece of Law Firms (March 2025)
Grand View Research, U.S. Legal Services Market Report (2024)
Stanford Law School Center on the Legal Profession, Regulatory Innovation at the Crossroads: Five Years of Data on Entity Licensing (2025)
Artificial Lawyer, “Private Equity Buys A Law Firm…What Next?” (February 2025)
Global Legal Post, PE-backed Lawfront scoops up sixth regional UK firm (January 2026)
Uplift Investors / BusinessWire, Formation of Orion Legal MSO (January 22, 2026)
Private Equity Stakeholder Project, Private Equity Healthcare Bankruptcies on the Rise (April 2024)
Texas Ethics Committee Opinion 704 (April 2025)
ABA Model Rule 5.4 (Professional Independence of a Lawyer)
World Justice Project, Rule of Law Index 2024
Legal Trends Report 2024
